Hospitals, distributors charge patients six times the cost for knee implants: NPPA
NPPA said hospitals and distributors make around 120% to 135% profits on various knee implantsmumbai Updated: Aug 05, 2017 01:03 IST
After capping prices of stents, the National Pharmaceutical Pricing Authority (NPPA) has indicated that it may take the same route for orthopaedic implants.
In a document released by the NPPA on Friday, it said distributors and hospitals make exorbitant profits on knee implants. The report showed that while the maximum landing price (import price) of knee replacement implants is Rs65,782, the MRP at which it is sold is Rs4,13,059 which is more than six times the landing price.
Giving example of specific knee implants, the report showed that while the maximum landing cost of tibial plate, which is used to resurface the tibia bone in the knee, is Rs17,492, its MRP is almost seven times — Rs 1,22,336.
The report added that hospitals and distributors make around 120% to 135% profits on various knee implants such as femoral, tibial plate, inserts and patella. Dr Pradeep Bhosale, head of hip and joint replacement surgery at Nanavati Hospital, said the number of knee and hip replacement surgeries has increased by 600 times in the past five years, but implants continue to be expensive for patients. “The government must have some control over the price of these implants. All the international companies, which manufacture these implants, have more or less the same prices,” he said.
He added the while some local companies have started manufacturing knee replacement implants, none of them are FDA approved. “We often choose imported implants owing to their better longevity. There are many Indian companies that now manufacture these implants, and they are nearly 40% cheaper compared to the imported ones,” he said.